INOVIO PHARMACEUTICALS, INC. Interest Income (Expense), Net
INOVIO PHARMACEUTICALS, INC. (INO) reported Interest Income (Expense), Net of -$66.55 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2020-03-12
- INOVIO PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2019-03-31 was -$66.55K, a 121.30% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2018-12-31 was -$169.30K.
- INOVIO PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2018-09-30 was $380.99K.
- INOVIO PHARMACEUTICALS, INC. interest income (expense), net for the quarter ending 2018-06-30 was $396.68K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$66.55K 10-Q · filed 2019-05-09 | -$235.85K derived: sum of 2 quarters · filed 2020-03-12 | $145.13K derived: sum of 3 quarters · filed 2020-03-12 | $541.82K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | -$169.30K 10-K · filed 2020-03-12 | $211.69K derived: sum of 2 quarters · filed 2020-03-12 | $608.37K derived: sum of 3 quarters · filed 2020-03-12 | $920.89K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-09-30 | $380.99K 10-K · filed 2020-03-12 | $777.67K derived: sum of 2 quarters · filed 2020-03-12 | $1.09M derived: sum of 3 quarters · filed 2020-03-12 | |
| 2018-06-30 | $396.68K 10-K · filed 2020-03-12 | $709.20K derived: sum of 2 quarters · filed 2020-03-12 | ||
| 2018-03-31 | $312.52K 10-K · filed 2020-03-12 | |||
| 2011-09-30 | $5.72K 10-Q · filed 2011-11-07 | $13.52K derived: sum of 2 quarters · filed 2011-11-07 | $26.30K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $7.80K 10-Q · filed 2011-08-05 | $20.57K 10-Q · filed 2011-08-05 | ||
| 2010-09-30 | $14.71K 10-Q · filed 2011-11-07 | $28.31K derived: sum of 2 quarters · filed 2011-11-07 | $62.87K 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $13.59K 10-Q · filed 2011-08-05 | $48.16K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |